Outcomes Associated with Nonconcordance to National Kidney Foundation Guideline Recommendations for Oral Antidiabetic Drug Treatments in Patients with Concomitant Type 2 Diabetes and Chronic Kidney Disease
Authors:
- 1 March 2014
- journal article
- Published by Elsevier in Endocrine Practice
- Vol. 20 (3) , 221-231
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney diseaseCurrent Medical Research and Opinion, 2012
- Review of statistical methods for analysing healthcare resources and costsHealth Economics, 2010
- The Effect of Iron and Erythropoietin Treatment on the A1C of Patients With Diabetes and Chronic Kidney DiseaseDiabetes Care, 2010
- Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implicationsDiabetic Medicine, 2010
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes MellitusDiabetes, 2009
- Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visitsBMC Endocrine Disorders, 2008
- Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic controlCurrent Medical Research and Opinion, 2007
- The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjectsNephrology Dialysis Transplantation, 2006
- Chronic renal diseases as a public health problem: Epidemiology, social, and economic implicationsKidney International, 2005